DecisionPoint Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
DecisionPoint Financial's GILD Position: Q3 2026 in Review
DecisionPoint Financial increased its Gilead Sciences (GILD) stake by 38% in Q3 2026, buying an estimated $702 and bringing the position to 18 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #349.
DecisionPoint Financial first reported a position in GILD in Q2 2025 and has held it in 6 quarters since. The position peaked at $7.24K in Q4 2025. 2,349 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- DecisionPoint Financial held 18 shares of Gilead Sciences worth $2.66K as of Q3 2026.
- DecisionPoint Financial bought 5 Gilead Sciences shares in Q3 2026, an estimated $702.
- Gilead Sciences made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #349 holding.
- DecisionPoint Financial first reported a position in Gilead Sciences in Q2 2025 and has held it in 6 quarters since.
- DecisionPoint Financial's Gilead Sciences position peaked at $7.24K in Q4 2025.
- 2,349 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.